Results 71 to 80 of about 781,361 (246)
Transcranial magnetic stimulation: the road to clinical therapy for dystonia
, 2023 Despite many research studies, transcranial magnetic stimulation (TMS) is not yet an FDA-approved clinical therapy for dystonia patients. This review describes the four major challenges that have historically hindered the clinical translation of TMS. The
Angel V. Peterchev +7 more
core +1 more source
Advanced Intelligent Systems, Volume 7, Issue 3, March 2025.Herein, a patient‐mounted neuro optical coherence tomography system that integrates a 5 degrees‐of‐freedom skull‐mounted robot (Skullbot) with a 0.6 mm neuroendoscope for targeted, minimally invasive deep brain imaging, is developed. The system offers high‐resolution imaging with precise deployment, demonstrated through successful tumor imaging in a ...
Chao Xu +7 more
wiley +1 more source
Journal of University College of Medicine and DentistryObjective: To describe the clinical patterns and types of focal dystonia among patients presenting to the neurology department of a tertiary care hospital in Karachi. Methodology: This descriptive cross-sectional study was undertaken at Dr. Ruth K. M.
Rabiya Khan +5 more
doaj +1 more source
Opsoclonus-Myoclonus-Ataxia Revealing Underlying Neuromyelitis Optica Spectrum Disorder. [PDF]
Mov Disord Clin PractMovement Disorders Clinical Practice, EarlyView.
Verde ASSL +6 more
europepmc +2 more sources
Severe Headbanging Responsive to Levodopa in a Child With FOXP1 Syndrome
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT We report a 9‐year‐old female with FOXP1 syndrome due to a de novo in‐frame deletion in the FOXP1 gene. The child has a severe neurodevelopmental disorder including global developmental delay and autism spectrum disorder. At age 2, she developed severe headbanging, which was progressive and did not respond to multidisciplinary, behavioral ...
Pamela Veale +2 more
wiley +1 more source
Facial dystonia – A rare initial presentation of acquired immune deficiency syndrome
, 2015 Movement disorders could be a neurological complication of acquired immune deficiency syndrome (AIDS) and may sometimes represent the initial manifestation of HIV (Human Immune Deficiency Virus) infection.
A. Saxena, A. Ramesh, P. Mehra, S. Manoj
semanticscholar +1 more source
Recurrent Neurodevelopmental Disorder Associated With a Dominant‐Negative TOP2B H63Y Variant
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT We describe a 7 year‐old boy with severe neurodevelopmental disorder, medically‐refractory epileptic encephalopathy, hyperkinetic movement disorder, hypotonia, cerebral and cerebellar atrophy and hypomyelination who was found to have a heterozygous de novo TOP2B NM_001330700.2:c.187C>T, p.(His63Tyr) variant.
Zong Yi Ha +6 more
wiley +1 more source
Neurodevelopmental disorder with dystonia due to SOX6 mutations
Molecular Genetics & Genomic Medicine, 2022 Background Mutations in SOX6 have recently been recognized as a new molecular cause of neurodevelopmental disorders characterized by intellectual disability, behavioral changes, and nonspecific facial and digital skeletal abnormalities. To date, T.
Susanne A. Schneider +4 more
doaj +1 more source
Frontiers in Human Neuroscience, 2021 Introduction: The clinical efficacy of deep brain stimulation (DBS) for midline tremor has been heterogenous. Here, we present an atypical case with facial and palatal tremor treated with DBS.
Takashi Morishita +7 more
doaj +1 more source
Blink reflex and the masseter inhibitory reflex in patients with dystonia.
, 1993 The excitatory and inhibitory interneuronal pathways in the brainstem are tested by examining the blink reflex and the masseter inhibitory reflex, respectively.
CRUCCU, Giorgio +6 more
core +1 more source